However, this protection is relative and can easily be overwhelmed by other risk factors
Am J Respir Cell Mol Biol
Brand-name semaglutide Ozempic and Wegovy are manufactured by Novo Nordisk
A major New England Journal of Medicine trial found that patients who discontinued semaglutide regained approximately two-thirds of lost weight within one year, while those who continued therapy maintained their results
This creates a need for better education, personalization, and stronger alignment between healthcare providers and nutrition brands
Keywords: GLP-1 receptor agonists, neuroprotection, neuroinflammation, Alzheimers disease, Parkinsons disease Introduction Neurological disorders are a leading cause of death and disability worldwide and place a huge burden on patients, families, and healthcare systems